Accumulative studies have demonstrated that immune system components, such as CD8+ and CD45RO+ memory T cells with specific cytokine signatures and possibly B cells, might be prognostic biomarkers, which is associated with tumor evolution with different presence 52-56. The gene discussed is CD8A; the disease is neoplasm.